Pharmacy Times November 20, 2023
The results suggest that telemedicine could be used to help improve access for other populations that might be stigmatized, beyond hepatitis C virus and opioid use disorder.
Telemedicine is more effective for treating and curing hepatitis C virus (HCV) for individuals with opioid use disorder (OUD) compared to usual care, according to results of a treatment program by individuals from the University at Buffalo. The findings, presented at the American Association for the Study of Liver Diseases, also demonstrated that the advantages of being cured impacted sustainable health and social benefits.
According to a press release, there have been few randomized controlled trials to determine the effectiveness of telemedicine in those who are underserved, including those with OUD and HCV....
Today's Sponsors
Today's Sponsor